David Mott

New Enterprise Associates General Partner

David Mott picture
$200k - $40.0m
$10.0m
CompanyDeal TypeAmountDate
Nightstar TherapeuticsSeries C$45MJun 2017
ArdelyxPost-IPO Equity$110MJul 2016
Nightstar TherapeuticsSeries B$35M (Lead)Nov 2015
Clementia PharmaceuticalsVenture Round$60M (Lead)Jun 2015
ArdelyxPost-IPO Equity$77.8M (Lead)Jun 2015
AdaptimmuneSeries A$104M (Lead)Sep 2014
CydanVenture Round$10MOct 2013
Edimer PharmaceuticalsSeries B$18M (Lead)Jul 2013
CydanVenture Round$16M (Lead)Apr 2013
ProsensaVenture Round€23M (Lead)Jan 2012
No media found for David Mott. Add it now.

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Aaron Jacobson picture

New Enterprise Associates

Albert Lee picture

New Enterprise Associates

AB

New Enterprise Associates

Amit Mukherjee picture

New Enterprise Associates

AS

New Enterprise Associates